Cambridge Vision Technology (CVT) is an integrated medical device company focused on delivering scientifically validated diagnostic tests & biomarkers for early detection and monitoring of ophthalmic, and neurodegenerative diseases.
Dogs of impulse. Such fun bumping into impulse 2023 alum Andrew Kadis (and his doggie Alba) of Cambridge Vision Technology at my local coffee spot. So nice for Cleo to have a buddy while we caught up on the amazing progesss Andrew and his team are making.
#impulsefamilyforlife#medtech
“Cambridge represents 18% of UK's tech value, with only 3% of the input! It produces over $16.9 in value for every dollar of VC investment. A testament to the potential when academia, entrepeneurship and venture capital converge”
Delighted for the opportunity to give a presentation about Cambridge Tech last week at Founders at the University of Cambridge's Demo Day in at Kings Place in London. Huge thanks to Gerard Grech for making this happen. A link to the PDF and some other data will follow in the comments.
Some takeaways:
🧬 Cambridge ranks third globally, following Boston, in terms of output per capita in scientific and engineering breakthroughs making their way to making their way into products and companies
📈 Cambridge represents 18% of UK's tech value, with only 3% of the input! It produces over $16.9 in value for every dollar of VC investment. A testament to the potential when academia, entrepeneurship and venture capital converge
🧪 Cambridge is the #1 university in Europe for producing spinouts, showcasing its robust pipeline of innovation
Great to see these findings got covered by BBC News TV, City AM, and others.
Curious about Cohort 1.0?
AetoSense – applying patented technology to drive precision in air quality monitoring, addressing potential health hazards
BioTryp Therapeutics – dividing bacteria to conquer infections and provide an alternative to traditional antibiotics, starting with urinary tract infections
BravelyCultured – using a proprietary marine microbial biobank and solid-state cultivation methods to replace animal- and petroleum-based products
Cambridge Vision Technology – early detection of Alzheimer’s
Molyon – creating next generation high-energy density batteries for weight-critical applications
Nanomation – building computer vision software for the semiconductor industry to enable clients to build products using advanced, complex nanomaterials
Orbit – using non-invasive nanotechnology to create a smart fitness device for brains, making mental health data transparent and actionable
Protonera – turning waste plastics into valuable commodities to make recycling work
VOLTQUANT – fixing the UK electricity grid to solve one of the biggest challenges preventing Net Zero
William Oak – developing a point-of-care test for micronutrient deficiencies to improve maternal, infant and child health
Xterna – engineering a cell-targeting platform that delivers therapeutic cargo to specific cell types
cc Dealroom.co, Orla Browne, Serena Connor
A big thanks to everyone who joined us yesterday at King’s Place for the first-ever Founders at the University of Cambridge Investor Demo Day for our Start 1.0 Accelerator companies. For the past 12 weeks, these 11 University of Cambridge companies have worked extremely hard to refine their propositions, work with EIRs and develop their technology into what we believe will be globally impactful businesses. They simply aced it in every way.
Covering life sciences, climate tech, biotech & materials science, yesterday was an opportunity for them to introduce their businesses to hundreds of top investors. For a deeper dive into each company in the Start Accelerator 1.0 Cohort go to our website here: https://lnkd.in/eUZEkpg4
🫧 AetoSense - low-cost and high-accuracy indoor air quality monitoring sensors
🦠 BioTryp Therapeutics - dividing bacteria to end over reliance on traditional antibiotics
🧪BravelyCultured - using proprietary technology to replace petroleum-based products
🧠 Cambridge Vision Technology Tech - early detection of Alzheimer’s
🔋 Molyon - next-generation lithium batteries
💻Nanomation - building computer vision software for the semiconductor industry
🎈Orbit - using non-invasive nanotechnology to transform mental health treatment
♻️Protonera - digesting plastic with sunlight
⚡VOLTQUANT - fixing the UK electricity grid to enable Net Zero
🩺 William Oak Diagnostics - developing effective testing for micronutrient deficiencies
🧫 Xterna - targeting bio-molecule therapy
A huge thanks to Yoram Wijngaarde of Dealroom.co who smashed it with his data on the Cambridge ecosystem. Also thanks to our panel of founders and investors discussing deep tech and its challenges. Including @Xampla’s Alexandra French, 52North - creators of Neutrocheck®’s Umaima Malik Ahmad, Quantum computing Riverlane’s Rebecca Simmons and Phoenix Court’s Saul Klein, with Bloomberg News’s Parmy Olson leading the discussion.
Finally, it was brilliant to hear from our Pro-Vice Chancellor for Innovation Diarmuid O'Brien and Vice Chancellor Deborah Prentice on the new structures in place at Cambridge, to ensure the city’s venture scientists are the best supported when it comes to taking their groundbreaking tech from the lab out to the world.
And a big thank you to everyone who helped make yesterday a success, from the teams at Founders and Cambridge Enterprise to our brilliant advisers and experts who give up their time to mentor the new generation and many others. And Anne Dobrée whose energy is infectious and the person who got this initiative going in the first place! Thank you for your leadership. And Mark Lazar our programme director who ushered the cohort through the highs and lows!
So much more to do with universities generally, which makes this whole space so exciting.
#spinouts#innovation#cambridgeuniversity#demoday
